
Sign up to save your podcasts
Or
Associate Professor Tomas Kalincik (University of Melbourne, Australia) discusses oral immunotherapies, and what we know about the effects of these treatments on patient relapse and disability. Read the full paper here: https://jnnp.bmj.com/content/early/2019/01/12/jnnp-2018-319831
4.6
77 ratings
Associate Professor Tomas Kalincik (University of Melbourne, Australia) discusses oral immunotherapies, and what we know about the effects of these treatments on patient relapse and disability. Read the full paper here: https://jnnp.bmj.com/content/early/2019/01/12/jnnp-2018-319831
280 Listeners
38 Listeners
5 Listeners
47 Listeners
7 Listeners
4 Listeners
3 Listeners
1 Listeners
3 Listeners
25 Listeners
40 Listeners
14 Listeners
1 Listeners
33 Listeners
0 Listeners
6 Listeners
17 Listeners
43,265 Listeners
111,658 Listeners
14 Listeners
3 Listeners
29 Listeners
23 Listeners
130 Listeners
174 Listeners
3 Listeners
0 Listeners
0 Listeners